Search This Blog

Friday, October 2, 2026

Abbott FDA-approved blood-based colorectal cancer screen for average-risk U.S. adults

 

Abbott launches SimpleScreen CRC, an FDA-approved blood-based colorectal cancer screening test for average-risk U.S. adults

  • Launch expands Abbott's colorectal cancer screening portfolio, complementing Cologuard Plus with a blood-based option for average-risk adults.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)